Nebula Research & Development’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-46,631
| Closed | -$163K | – | 969 |
|
|
2024
Q3 | $163K | Sell |
46,631
-11,734
| -20% | -$41.1K | 0.02% | 849 |
|
|
2024
Q2 | $191K | Buy |
+58,365
| New | +$191K | 0.03% | 732 |
|
|
2023
Q4 | – | Sell |
-163,617
| Closed | -$347K | – | 719 |
|
|
2023
Q3 | $347K | Buy |
163,617
+121,025
| +284% | +$257K | 0.18% | 231 |
|
|
2023
Q2 | $203K | Buy |
+42,592
| New | +$203K | 0.15% | 271 |
|